Cited by 627Pluripotent Stem Cells ResearchNeurogenesis and neuroplasticity mechanismsDevelopmental Biology and Gene Regulation

Hierarchical Mechanisms for Direct Reprogramming of Fibroblasts to Neurons

Open access
Wapinski, Orly L., Vierbuchen, Thomas, Qu, Kun, Lee, Qian Yi, Chanda, Soham, Fuentes, Daniel R., Giresi, Paul G., Ng, Yi Han +11 more·2013·Cell

Abstract

Direct lineage reprogramming is a promising approach for human disease modeling and regenerative medicine, with poorly understood mechanisms. Here, we reveal a hierarchical mechanism in the direct conversion of fibroblasts into induced neuronal (iN) cells mediated by the transcription factors Ascl1, Brn2, and Myt1l. Ascl1 acts as an "on-target" pioneer factor by immediately occupying most cognate genomic sites in fibroblasts. In contrast, Brn2 and Myt1l do not access fibroblast chromatin productively on their own; instead, Ascl1 recruits Brn2 to Ascl1 sites genome wide. A unique trivalent chromatin signature in the host cells predicts the permissiveness for Ascl1 pioneering activity among different cell types. Finally, we identified Zfp238 as a key Ascl1 target gene that can partially substitute for Ascl1 during iN cell reprogramming. Thus, a precise match between pioneer factors and the chromatin context at key target genes is determinative for transdifferentiation to neurons and likely other cell types.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.cell.2013.09.028

Cites

50 of 50 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • BAZ1B binding regions are enriched for target sites of major regulators of neural crest and its neural derivatives, among which TFAP2A stands out given its core role in neural border formation and neural crest induction and differentiation through binding and stabilization of neural-crest-specific enhancers with NR2F1, NR2F2, and EP300.

    “Thus, BAZ1B binding regions are enriched for target sites of major regulators of NC and its neural derivatives (38, 39), among which TFAP2A stands out given its core role in neural border formation and NC induction and differentiation (40) through the binding and stabilization of NC-specific enhancers, in concert with NR2F1, NR2F2, and EP300 (41).”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

1 retracted

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Wapinski, O. L., Vierbuchen, T., Qu, K., Lee, Q. Y., Chanda, S., Fuentes, D. R., Giresi, P. G., Ng, Y. H., Marro, S., Neff, N. F., Drechsel, D., Martynoga, B., Castro, D. S., Webb, A. E., Südhof, T. C., Brunet, A., Guillemot, F., Chang, H. Y., & Wernig, M.
Affiliations
  • Howard Hughes Medical Institute (US)
  • Stanford Medicine (US)
  • Stanford University (US)
  • National Institute for Medical Research (GB)
  • Instituto Gulbenkian de Ciência (PT)
Corresponding author
  • Chang, Howard Y.
  • Wernig, Marius
Venue
Cell
Publisher
Elsevier BV
Published
2013-10
Volume
155
Issue
3
Pages
621-635
ISSN
0092-8674 (ISSN-L)
OpenAlex
W2068478010
Cited by
627
References
50
Citations by year
2026: 27 · 2025: 33 · 2024: 39 · 2023: 54 · 2022: 46 · 2021: 62 · 2020: 55 · 2019: 62 · 2018: 55 · 2017: 53 · 2016: 54 · 2015: 51 · 2014: 33 · 2013: 3
FWCI
21.07
Type
journal article
Language
en
Open access
Locations
  • Cell (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Institute on Aging (P01AG036695)
  • National Cancer Institute (T32CA009302)
  • National Institute of Neurological Disorders and Stroke (RC4NS073015)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
  • Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
Keywords
fibroblast-to-neuron conversion, ASCL1, Brn2, MYT1L, pioneer transcription factors, chromatin accessibility, chromatin signatures, transdifferentiation, transcriptional hierarchy
MeSH terms
Animals, Cell Differentiation, Chromatin, Embryo, Mammalian, Fibroblasts, Humans, Nerve Tissue Proteins, Neurons, Repressor Proteins, Transcription Factors, POU Domain Factors, Mice, Basic Helix-Loop-Helix Proteins, Basic Helix-Loop-Helix Transcription Factors, Gene Regulatory Networks, Genome-Wide Association Study, Cellular Reprogramming

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review